TGFB1 and Peritoneal Fibrosis: In summary, we have demonstrated that sinefungin, an inhibitor of SET7/9, attenuates not only MGO-induced peritoneal fibrosis in mice but also TGF-β1-induced fibrotic changes in HPMCs by reducing H3K4me1 levels.